Adds tianeptine sodium to the list of Schedule II of controlled substances

This bill adds tianeptine sodium to New York's Schedule II list of controlled substances under public health law. Schedule II classification means it will require strict prescription controls and limit distribution due to its high potential for abuse and accepted medical use. The change directly affects healthcare providers who prescribe it, pharmacies that dispense it, and individuals using the substance. This policy shift formalizes existing regulatory restrictions on tianeptine sodium as a controlled substance.